Money Concepts Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Money Concepts Capital's GILD Position: Q2 2026 in Review
Money Concepts Capital reduced its Gilead Sciences (GILD) stake by 28% in Q2 2026, selling an estimated $2.93M and leaving 57,614 shares worth $7.28M. The position accounts for 0.34% of the portfolio, ranked #63.
Money Concepts Capital first reported a position in GILD in Q4 2020 and has held it in 21 quarters since. The position peaked at $24.5M in Q4 2022. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Money Concepts Capital held 57,614 shares of Gilead Sciences worth $7.28M as of Q2 2026.
- Money Concepts Capital sold 22,243 Gilead Sciences shares in Q2 2026, an estimated $2.93M.
- Gilead Sciences made up 0.34% of Money Concepts Capital's portfolio in Q2 2026, its #63 holding.
- Money Concepts Capital first reported a position in Gilead Sciences in Q4 2020 and has held it in 21 quarters since.
- Money Concepts Capital's Gilead Sciences position peaked at $24.5M in Q4 2022.
- 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Money Concepts Capital's 13F filing for Q2 2026, filed 4 Aug 2026.